Duloxetine

Product NDC
71610-743
11-digit product format
716100743
Labeler code
71610
Product ID
71610-743_3724601a-53f8-5bd3-e063-6394a90a98a6
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
DULOXETINE HYDROCHLORIDE
Dosage form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Application
ANDA203088
Marketing category
ANDA
Marketing start
2014-06-11
Substance
DULOXETINE HYDROCHLORIDE
Active strength
60 mg/1
Pharmacologic classes
Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Duloxetine
Brand name suffix
Delayed-Release
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
DULOXETINE HYDROCHLORIDE60 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii9044SC542W
Rxcui596934

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
71610-743-307161007433030 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (71610-743-30) 2023-10-16NoNoHistorical
71610-743-537161007435360 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (71610-743-53) 2023-10-16NoNoHistorical
71610-743-607161007436090 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (71610-743-60) 2023-10-16NoNoHistorical
71610-743-7471610074374500 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (71610-743-74) 2025-06-05NoNoHistorical
71610-743-8071610074380180 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (71610-743-80) 2024-03-20NoNoHistorical